2N8I

Solution NMR Structure of Designed Protein DA05, Northeast Structural Genomics Consortium (NESG) Target OR626

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
2	2D CT 1H-13C HSQC aliphatic	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
3	2D CT 1H-13C HSQC aromatic	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
4	3D 15N/13C-edited 1H-1H NOESY	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
5	(4,3)D GFT HCCH-COSY aliphatic	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
6	(4,3)D GFT HCCH-COSY aromatic	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
7	(4,3)D GFT HNNCACBCA	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
8	3D HCCH-TOCSY	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
9	3D HNCO	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
10	3D HN(CA)CO	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
11	(4,3)D GFT CABCA(CO)NHN	600 uM [U-13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
12	2D CT 1H-13C HSQC aliphatic 28 ms	200 uM [U-5% 13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
13	2D CT 1H-13C HSQC aliphatic 42 ms	200 uM [U-5% 13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298
14	2D CT 1H-13C HSQC aliphatic 56 ms	200 uM [U-5% 13C; U-15N] DA05, 25 mM sodium phosphate, 50 mM sodium chloride, 0.02 % sodium azide, 0.5 mM PMSF, 50 uM DSS	90% H2O/10% D2O		6.5	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	INOVA	750

NMR Refinement
Method	Details	Software
simulated annealing		PROSA

NMR Ensemble Information
Conformer Selection Criteria	target function
Conformers Calculated Total Number	100
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	PROSA	6.4	Guntert
2	structure solution	AS-DP	1.0	Huang, Tejero, Powers and Montelione
3	refinement	CNS	1.3	Brunger, Adams, Clore, Gros, Nilges and Read
4	data analysis	CARA	1.8.4	Keller and Wuthrich
5	peak picking	CARA	1.8.4	Keller and Wuthrich
6	chemical shift assignment	CARA	1.8.4	Keller and Wuthrich
7	structure solution	CYANA	3.0	Guntert, Mumenthaler and Wuthrich
8	data analysis	XEASY	1.3.13	Bartels et al.
9	collection	VnmrJ	4.0	Varian
10	geometry optimization	TALOS-N		Cornilescu, Delaglio and Bax
11	structure validation	PSVS	1.5	Bhattacharya and Montelione
12	chemical shift assignment	AutoAssign	2.3.0	Zimmerman, Moseley, Kulikowski and Montelione
13	refinement	CYANA	3.0	Guntert, Mumenthaler and Wuthrich

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.